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Toll-like receptors (TLRs) are a family of widely distributed cellular structures that are activated by the recognition of pathogenassociated molecular sequences/patterns. The primary role of TLRs is attributed to the protection of the host from invading microorganisms [1]. The activation of TLRs triggers a variety of intracellular mechanisms and transcription factors depending on the receptor and cell type. TLR4 belongs to the TLRs for lipasebased pathogen-associated molecular sequences/patterns having lipopolysaccharide (LPS, a glycolipid component of the outer membrane of gram-negative bacteria) as the main ligand
. [3, 4] . [5] , certain fatty acids [6] , minimally modified LDL and oxidized-LDL [7] . In the present study we show a new endogenous ligand for TLR4.
Intracellular signalling following ligation of the TLR4/ myeloid differentiation factor 2 (MD2) complex is achieved through human myeloid differentiation factor 88 (MyD88) resulting in nuclear migration of nuclear factor-B (NF-B) transcription factor
Translocation of this transcription factor inevitably leads to a burst of pro-inflammatory cytokines, proteolytic enzymes and adhesion molecules. LPS is known as the main ligand for TLR4. Recently, the presence of endogenous ligands potently activating TLR4 has been reported including hyaluronan, fibronectin and heat shock proteins (HSP60, HSP70). TLR4 mediated effects have been also demonstrated for HMGB-1
Resistin is a 12.5-kD protein, a member of a cysteine-rich protein family [8] . Resistin (RELM␣ and RELM␤) [9] . Human resistin exhibits only 59% amino acid homology to its murine counterpart, predominantly in the cysteine-rich regions [10, 11] 
. Resistin was originally described as an adipocyte-derived polypeptide modulating the insulinsignalling pathway leading to insulin resistance in obese mice
Resistin competes with lipopolysaccharide for binding to toll-like receptor 4 [8, 12] . Indeed, in mice resistin is almost exclusively expressed in white adipose tissue, while in man resistin is not expressed in adipocytes [13, 14] and has no direct relation to obesity or insulin sensitivity. In contrast, high levels of human resistin are expressed by mononuclear leucocytes, spleen and bone marrow cells [15] followed by lung tissue, resting endothelial cells and placenta [16] .
Resistin has been described as a protein 'found in the inflammatory zone' (FIZZ) . Increased expression of resistin has been reported in chronic liver diseases [17, 18] , lung diseases [12] , in atherosclerotic plaques [19] , inside inflamed joints [20, 21] and in inflammatory kidney disease [22, 23] . Resistin has recently attracted attention as a predictive factor for atherosclerosis progression [24] , vascular re-occlusion and kidney function in its inflammatory diseases [25] . In the above mentioned conditions, resistin levels showed a strong correlation to other inflammatory markers such as C-reactive protein [17, 24, 25] , tumour necrosing factor (TNF)-␣ [17] , interleukine (IL)-6 [20] and soluble vascular adhesion molecules [25] . [19, 26] . Resistin exhibits mitogenic properties towards human endothelial [27, 28] and smooth muscle cells [29] [18, 20] , regulates matrix remodelling in human trophoblast by up-regulating matrix metalloproteinases and down-regulating TIMPs [30] and induces joint inflammation when injected intra-articularly [20] . Participation of resistin in lipid utilization and bone remodelling [15] (Fig. 1C5,6 ). Fig. 2A) and resistin (Fig. 2B) 
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Resistin forms a complex with TLR4 on the cell surface
Fig. 1 Resistin binding to human leucocytes and epithelial cells. (A) Human leucocytes obtained from peripheral blood were incubated for 30 min with human recombinant resistin (500 ng/ml), washed and cell bound resistin was visualized by anti-resistin antibodies using flow cytometry. Pronounced binding of resistin to lymphocyte and monocyte cell population was observed. (filled area). In contrast, neutrophils display significant expression of resistin on their cell surface prior to incubation with exogenous resistin. (B) THP1 monocytic cells bind exogenous resistin in a dose-dependent manner (B1
Functional properties of resistin are dependent on its interaction with TLR4
To assess the functional role of resistin-TLR4 interaction on the induction of pro-inflammatory responses, PBMC were treated with TLR4 antibodies (dose range 0-1-5-10 g/ml), and stimulated with recombinant resistin (250 and 1000 ng/ml) and assessed for expression of IL-6 (Fig. 3A) and IL-8 (Fig. 3B) (Fig. 3A, B) . A prototypic TLR4 ligand, LPS, was used as a positive control. Specificity of resistin to trigger cytokine secretion in the above experimental setting was proved by an abrogation of resistin-but not LPS-induced effects by the addition of anti-resistin antibodies (Fig. 3B) . Figure 3 Fig. 5A ). (Fig. 1C2) and resistin-induced secretion of IL-8 was diminished in the presence of CD14-specific antibodies (Fig. 5C) . In contrast, HEK293 transfected with MD2/CD14 genes did not respond to resistin stimulation with IL-8 secretion (Fig. 5C) indicating that the presence of these surface proteins was not sufficient for mediation of resistin effects.
(C) confirms the requirement of TLR4 for resistin induced effects when HEK293 cells transfected with TLR4 (HEK-TLR4), TLR2 (HEK-TLR2) and empty vector (HEK-null) are stimulated with recombinant resistin. Resistin induced a significant expression of IL-8 in the TLR4 transfected cells that was not observed in the TLR2 transfected cells or in HEK-null cells transfected with an empty vector (Fig. 3C). The ligands of TLR2 (synthetic peptidoglycan, PamCys) and of TLR-4 (LPS) were used as positive controls. Pre-incubation of resistin with anti-resistin antibodies but not with isotype matched mouse IgG resulted in a reduction of IL-8 secretion in HEK-TLR4 cells. Collectively, these results prove that TLR4 is an important receptor and mediator of resistin-induced production of cytokines.
Resistin competes with LPS for binding to TLR4
LPS is the main ligand and has by far the highest affinity for TLR4. To evaluate a role of resistin in the LPS-induced production of pro-inflammatory cytokines, a competitive stimulation of cell cultures was performed. Human PBMC (n ϭ 3) were treated with increasing amounts of resistin for 1 hr followed by stimulation with LPS. The measurement of IL-6 in the supernatants showed that resistin significantly diminished the LPS-induced synthesis of IL-6 (Fig. 4A). Analogous results were obtained when HEK-TLR4 cells were treated with LPS and stimulated with resistin (Fig. 4B). Thus, resistin serves as an endogenous inhibitor of LPS-induced effects, probably by competing for binding to TLR4. A contamination of TLR4 ligands with LPS is an important issue in our study and was, therefore, carefully addressed. Neutralization of resistin using specific monoclonal antibodies almost totally abrogated its cytokine releasing properties, indicating that potential low-grade LPS contamination was not responsible for the effects studied. © 2009 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 2 Western blot analysis of the membrane fraction of THP1 cells (1 ϫ 10 7 ) incubated with resistin (500 ng/ml). The equal protein amounts of membrane extracts were precipitated using mouse anti-resistin antibodies (7.5 g), anti-TLR4 antibodies (10 g) or non-specific mouse IgG (10 g), followed by incubation with protein A/protein G sepharose beads. Immunoprecipitates obtained by precipitation with either TLR4 ab or resistin ab were subjected to electrophoresis and immunoblotting using TLR4 ab (A). Immunoprecipitates obtained by precipitation with either TLR4 ab, resistin ab or non-specific control ab were subjected to electrophoresis and immunoblotting using resistin antibodies (B). Coprecipitation of TLR4 in the resistin bound membrane fraction is clearly visible. Sensitivity of the system for resistin was tested using various concentrations of human recombinant resistin (C).
The requirement of TLR pathways for resistininduced intracellular signalling
To additionally prove the existence of TLR4 on the cell surface for the pro-inflammatory effects of resistin, HEK-TLR4 cells were transfected with siRNA targeting TLR4 (20 and 100 nM) and nontargeting siRNA sequence (100 nM) (Fig. 5A). The post-transfectional inhibition of TLR-4 was proved by flow cytometry and by Western blot analysis. The HEK-TLR4 cells that underwent inhibition of TLR-4 lost its ability to respond stimulation with resistin © 2009 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 3 Resistin-induced production of cytokines in human PBMC is dependent on TLR4 expression. Secretion of (A) IL-6 and (B) IL-8 in human PBMC
For LPS recognition, human cells require a complex consisting of TLR4 in assembly with CD14 and MD2 molecules (4). Interaction between TLR4 and resistin was dependent on the presence of CD14 since resistin binding to HEK-TLR4 cells
Intracellular pathways mediating resistin effects
We have recently shown that resistin induces activation of the NF-B pathway [20] . To (Fig. 6A-C) and protein levels (Fig. 6D-F (Fig. 6) . The PI3-kinase has been previously shown as an intracellular inhibitor of TLR2 and TLR4 mediated effects [32, 33] . (Fig. 7B) [6, 36] and loss of TLR4 function prevented diet-induced obesity and insulin resistance [37, 38] . [32, 33] . PI3-kinase is known as a regulator of intracellular signalling originating from insulin and insulin-like receptors [38, 39] . Resistin has been shown to suppress PI3-kinase signalling by up-regulating the PI3-kinase inhibitor PTEN [40] . This 
Fig. 4 Resistin competes with LPS for binding to TLR4. (A) Treatment of human PBMC (n ϭ 3) with resistin (250 and 1000 ng/ml) significantly diminished secretion of IL-6 in response to LPS. (B) Analogous reduction of LPS-induced production of IL-8 was observed in HEK-TLR4 cells cultured in the presence of resistin.
Fig. 5 TLR4 is required for the induction of IL-8 expression in HEK293 cells in response to stimulation with resistin. (A) Down-regulation of TLR4 and MyD88 synthesis was achieved by transfecting HEK-TLR4 cells with siRNA sequences specific for these genes. This resulted with a decrease of IL-8 production in response to resistin as well as LPS stimulation in the siRNA transfected cell cultures (*P Ͻ 0.05). (B) Downregulation of MyD88 synthesis in HEK-TLR4 cells transfected with MyD88-specific siRNA and not non-targeting siRNA sequence is shown following 48 and 72 hrs incubation time. (C) Resistin-induced secretion of IL-8 in HEK-TLR4 cells is significantly reduced following incubation with anti-CD14 and anti-resistin antibodies. In contrast, transfection of HEK293 cells with MD2/CD14 in the absence of TLR4 did not lead to resistin-induced activation of HEK293 cells. signalling pathways in the resistin-mediated effects, the inhibitors specific for regulation of NF-B (parthenolide), MAP-kinases (p44/p42, PD98059 and p38, SB203580) and PI3-kinase (LY294002) were introduced to the PBMC cultures 1 hr prior to stimulation with resistin (Fig. S1). Evaluation of cytokine expression showed that the inhibitors of NF-B and MAP-kinases efficiently inhibited resistin-induced expression of IL-6, TNF-␣ and IL-1␤ on the mRNA
) in human PBMC (n ϭ 5). The observed inhibitory effects had a dose-dependent pattern (not shown). In contrast, the inhibition of PI3-kinase increased the effect of resistin leading to potentiation of the cytokine expression
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ml). Cell cultures were evaluated for the expression of IL-6, TNF-␣, and IL-1␤ on mRNA level (A-C) and on protein level (D-F). We observed that inhibitors of NF-B and MAP-kinases significantly diminished resistin-induced expression of cytokines, while the inhibitor of PI3-kinase increased resistin stimulation. Differences in cytokine expression
